Cancer Stem Cell Marker Expression in Muscle-Invasive Urothelial Carcinoma.

被引：0
|
作者：
Diaz, E. [1 ]
Ching, C. B. [1 ]
Elson, P. [1 ]
Hansel, D. E. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
791
引用
收藏
页码：188A / 188A
页数：1
相关论文
共 50 条
  • [21] Muscle-invasive Urothelial Carcinoma: Nivolumab versus Placebo
    Lorenz, Judith
    AKTUELLE UROLOGIE, 2022, 53 (02) : 110 - 110
  • [22] Adjuvant Therapy in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma
    Achkar, Tala
    Parikh, Rahul A.
    UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) : 257 - +
  • [23] The journey of determining PD-L1 expression in muscle-invasive urothelial carcinoma
    Algaba, F.
    ACTAS UROLOGICAS ESPANOLAS, 2024, 48 (08): : 553 - 554
  • [24] Novel agents for muscle-invasive and advanced urothelial cancer
    Sonpavde, Guru
    Ross, Robert
    Powles, Thomas
    Sweeney, Christopher J.
    Hahn, Noah
    Hutson, Thomas E.
    Galsky, Matthew D.
    Lerner, Seth P.
    Sternberg, Cora N.
    BJU INTERNATIONAL, 2008, 101 (08) : 937 - 943
  • [25] Organ preservation in muscle-invasive urothelial bladder cancer
    Niglio, Scot A.
    Purswani, Juhi M.
    Schiff, Peter B.
    Lischalk, Jonathan W.
    Huang, William C.
    Murray, Katie S.
    Apolo, Andrea B.
    CURRENT OPINION IN ONCOLOGY, 2024, 36 (03) : 155 - 163
  • [26] Muscle-invasive Urothelial Carcinoma: Nivolumab versus Placebo Comment
    Seitz, Anna Katharina
    AKTUELLE UROLOGIE, 2022, 53 (02) : 112 - +
  • [27] Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
    Thomas Sanford
    Maxwell V. Meng
    Reema Railkar
    Piyush K. Agarwal
    Sima P. Porten
    Clinical Epigenetics, 2018, 10
  • [28] Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma
    Sanford, Thomas
    Meng, Maxwell V.
    Railkar, Reema
    Agarwal, Piyush K.
    Porten, Sima P.
    CLINICAL EPIGENETICS, 2018, 10
  • [29] Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
    Bajorin, D. F.
    Witjes, J. A.
    Gschwend, J. E.
    Schenker, M.
    Valderrama, B. P.
    Tomita, Y.
    Bamias, A.
    Lebret, T.
    Shariat, S. F.
    Park, S. H.
    Ye, D.
    Agerbaek, M.
    Enting, D.
    McDermott, R.
    Gajate, P.
    Peer, A.
    Milowsky, M., I
    Nosov, A.
    Antonio Jr, J. N.
    Tupikowski, K.
    Toms, L.
    Fischer, B. S.
    Qureshi, A.
    Collette, S.
    Unsal-Kacmaz, K.
    Broughton, E.
    Zardavas, D.
    Koon, H. B.
    Galsky, M. D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (22): : 2102 - 2114
  • [30] Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasize
    Domanowska, Ewa
    Jozwicki, Wojciech
    Domaniewski, Jan
    Golda, Ryszard
    Skok, Zdzislaw
    Wisniewska, Halina
    Sujkowska, Renata
    Wolski, Zbigniew
    Jozwicka, Grazyna
    HUMAN PATHOLOGY, 2007, 38 (05) : 741 - 746
12345